There are still some pharmaceutical manufacturers who believe maintaining internal teams for manual chargeback processing saves money.  Advances in technology and market competition have dramatically reduced the cost of more efficient solutions. Embracing a new strategy for processing chargebacks is necessary because wholesalers have increasingly sophisticated systems that can overwhelm manual processing, resulting in reduced cost control and increased financial risk.  A new suite of automated...

New policies, equipment and infrastructure upgrades, additional capabilities, programs and event participation are highlighted each month to demonstrate our ongoing commitment to client satisfaction.   SCWISH:PHARMA REGISTRATION OPEN The industry-driven event providing solutions to supply chain challenges attracts marketing, operations and compliance professionals to Boca Raton, FL November 14-15. Click here to learn more   ‘CULTURE AND CAREERS’ LAUNCHES ON WDSRX.COM Create...

  INTRODUCTION Pharmaceutical development and manufacturing are complex processes.  When a medication is approved for commercial use, the sales pathway between the manufacturer and patient involves multiple parties. Each step adds contract terms that specify requirements for price, storage, fulfillment and payment. The manufacturer must actively engage with all parties to minimize revenue loss. Chargebacks are an important component of the payment process that can reduce revenue loss when ...